Summary
A collective approach to early disease detection may transform cancer care. This study evaluated a new blood test for early detection of multiple cancers. In a small patient group, the multi-cancer early detection (MCED) test accurately identified the cancer’s origin in about 90% of cases. MCED tests offer potential for wider screening and early diagnosis but face challenges like specialist access, false positives, and follow-up issues.